Tectonic Therapeutic (TECX) Interest & Investment Income (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Interest & Investment Income of $2.2 million for Q1 2026, down 10.76% year-over-year from $2.4 million in Q1 2025, and down 14.94% quarter-over-quarter from $2.6 million in Q4 2025.
Powered by 
Analysis
Tectonic Therapeutic (TECX) Interest & Investment Income (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Interest & Investment Income for 10 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income fell 10.76% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $11.0 million (up 71.1% YoY), while the FY2025 annual figure was $11.3 million, up 165.13% from the prior year.
- Interest & Investment Income retreated to $2.2 million in Q1 2026 per TECX's latest filing, from $2.6 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $3.4 million in Q2 2025 and bottomed at -$370000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $1.1 million across 5 years, with a median of $256000.0 in 2024.
- On a YoY basis, Interest & Investment Income climbed as much as 5450.0% in 2022 and fell as far as 3800.0% in 2022.
- Tectonic Therapeutic's Interest & Investment Income stood at $245000.0 in 2022, then plunged by 45.71% to $133000.0 in 2023, then jumped by 1204.51% to $1.7 million in 2024, then jumped by 47.78% to $2.6 million in 2025, then declined by 14.94% to $2.2 million in 2026.
- Business Quant data shows TECX's Interest & Investment Income at $2.2 million in Q1 2026, $2.6 million in Q4 2025, and $2.9 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Tectonic Therapeutic | 584.94 Mn | 584.94 Mn | - | 2.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.02 Mn |
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 2.56 Mn |
| Sep 30, 2025 | 2.90 Mn |
| Jun 30, 2025 | 3.39 Mn |
| Mar 31, 2025 | 2.44 Mn |
| Dec 31, 2024 | 1.74 Mn |
| Sep 30, 2024 | 1.95 Mn |
| Jun 30, 2024 | 318,000.00 |
| Mar 31, 2024 | 256,000.00 |
| Dec 31, 2023 | 133,000.00 |
| Sep 30, 2023 | 97,000.00 |
| Jun 30, 2023 | 224,000.00 |
| Mar 31, 2023 | 248,000.00 |
| Dec 31, 2022 | 245,000.00 |
| Sep 30, 2022 | 111,000.00 |
| Jun 30, 2022 | -285,000.00 |
| Mar 31, 2022 | -370,000.00 |
| Dec 31, 2021 | -245,000.00 |
| Sep 30, 2021 | 2,000.00 |